Todd Davenport on The Impacts of Long COVID
Todd Davenport, Professor and Chair, Department of Physical Therapy, University of the Pacific, shared on LinkedIn:
”Our latest manuscript, “ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two‑Day Cardiopulmonary Exercise Testing,” is now posted as a preprint.
Using two‑day cardiopulmonary exercise testing (CPET), we compared physiologic responses in people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and matched non‑disabled controls, stratifying our analysis by sex.
Here’s what we learned:
- Both ME/CFS and Long COVID show similar failure to recover after exertion
- Largest impairments occur at the ventilatory anaerobic threshold, suggesting similar aerobic system impairment
- Females exhibited more pronounced post‑exertional abnormalities than males
- No meaningful differences were observed between ME/CFS and Long COVID on two-day CPET, suggesting they share a bioenergetic pathophysiology
- Severe functional impairment was common in both patient groups and was not explained by effort preference, deconditioning, ventilation, or hemodynamics
These results reinforce post‑exertional malaise (PEM) is a measurable physiological phenomenon.
They underscore the value of two‑day CPET to:
– Differentiate PEM from normal recovery using objective measures
– Inform disability evaluations in people who can and choose to have a CPET
– Improve precision in rehabilitation and treatment trials
I’m grateful to my co‑authors and to the patients.
Their generous engagement continues to advance our understanding of these terribly disabling yet largely ignored chronic conditions.”
Read the full article here.
Article: ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing
Authors: Todd Davenport, Staci Stevens, Jared Stevens, Mark Van Ness
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers